Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil–Based Chemotherapy-Reference-Cited by-同舟云学术

Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil–Based Chemotherapy

Published:2014-02 Issue:2 Volume:146 Page:401-411.e1
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Collura Ada,Lagrange Anaïs,Svrcek Magali,Marisa Laetitia,Buhard Olivier,Guilloux Agathe,Wanherdrick Kristell,Dorard Coralie,Taieb Anna,Saget Arnaud,Loh Marie,Soong Richie,Zeps Nikolajs,Platell Cameron,Mews Andrew,Iacopetta Barry,De Thonel Aurélie,Seigneuric Renaud,Marcion Guillaume,Chapusot Caroline,Lepage Come,Bouvier Anne–Marie,Gaub Marie–Pierre,Milano Gérard,Selves Janick,Senet Patrick,Delarue Patrice,Arzouk Hayat,Lacoste Claire,Coquelle Arnaud,Bengrine–Lefèvre Leila,Tournigand Christophe,Lefèvre Jérémie H.,Parc Yann,Biard Denis S.,Fléjou Jean–François,Garrido Carmen,Duval Alex

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Clues to the pathogenesis of familial colorectal cancer;Aaltonen;Science,1993

2. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis;Ionov;Nature,1993

3. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer;Fishel;Cell,1993

4. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer;Ribic;N Engl J Med,2003

5. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer;Carethers;Gastroenterology,2004

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer;Biomarker Research;2024-08-26

2. Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms;Annals of Surgical Oncology;2024-07-10

3. A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma;Journal of Experimental & Clinical Cancer Research;2024-05-22

4. Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen;Scientific Reports;2023-06-02

5. Editorial: Microsatellite and microsatellite instability;Frontiers in Genetics;2023-05-30